AKRX News 33.93 08/01/2014 04:29:16 Akorn Inc (AKRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 33.93 $AKRX

Akorn Shares Up 38.2% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 31, 5:16PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 38.21% as of today's recent price of $33.93.

Global Parkinson's Disease Market 2014-2018: Key Vendors are Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva
M2 - Thu Jul 31, 5:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l95k93/global) has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson's disease such as tremor, bradykinesia, and muscular rigidity. It is usually diagnosed in the population aged 60 and over; however, earlier incidences have been reported. Based on the severity, it can be categorized into early stage, mid stage and late (or advanced) stage. Currently, the approved therapies provide only symptomatic relief. Levodopa is the standard drug for the treatment of Parkinson's disease; however, it is associated with the incidence of dyskinesias. Alternative surgical procedures such as bilateral globus pallidus interna stimulation and bilateral subthalamic nucleus stimulation can be used in Parkinson's disease patients under certain circumstances. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by MOA 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Late-Stage Pipeline Candidates 18. Other Prominent Vendors 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - Boehringer Ingelheim GmbH - GlaxoSmithKline plc - Novartis AG - Teva Pharmaceutical Industries Ltd. - Abbvie Inc. - Akorn Inc. - Astellas Pharma Inc. - Desitin Arzneimittel GmbH - Endo International plc - F. Hoffmann-La Roche Ltd. - H. Lundbeck A/S - Kyowa Hakko Kirin - Merck & Co. Inc. - Orion Corp. - STADA Arzneimittel AG - UCB Inc. - US WorldMeds LLC - Valeant Pharmaceuticals International Inc. For more information visit http://www.researchandmarkets.com/research/l95k93/global

Uptrend Call Working As Akorn Stock Rises 41.5% (AKRX)
Comtex SmarTrend(R) - Thu Jul 24, 4:41PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 41.47% as of today's recent price of $34.73.

Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:46AM CDT
Acasti Pharma (ACST) was a big mover last session, with shares rising over 7% on the day.

Uptrend Call Working As Akorn Stock Rises 35.7% (AKRX)
Comtex SmarTrend(R) - Thu Jul 17, 11:02AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 35.72% as of today's recent price of $33.32.

Market Losses Its Swagger In Afternoon Trade
at Investor's Business Daily - Wed Jul 16, 3:26PM CDT
Wednesday's stock market opened with a swagger, but closed with a stagger as it gave up a good chunk of a morning bounce. The Nasdaq rose 0.2%; the S&P 500 and the Dow Jones industrial average gained 0.4%. Volume was higher on the Nasdaq and lower on...

Stocks Recover From Early Fade; Whiting Hits New High
at Investor's Business Daily - Wed Jul 16, 12:35PM CDT
Stocks were again off their session highs but have regained some momentum. The Nasdaq, S&P 500 and Dow Jones industrial average were each up 0.4%. Earlier, the Nasdaq and S&P 500 retraced most of their morning gains. Turnover was again tracking mixed...

Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 7:44AM CDT
Adamas Pharmaceuticals, Inc. (ADMS) was a big mover last session, as the company saw its shares rise 7% on the day.

Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
GlobeNewswire - Wed Jul 16, 3:52AM CDT
Akorn, Inc. (Nasdaq:AKRX) will host a conference call on Tuesday, August 5, 2014, to discuss second quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 7:44AM CDT
Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session, as the company saw its shares rise over 8% on the day.

Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...

Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.

Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...

Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.

Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.

Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.

Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.

Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...

Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week
at Investor's Business Daily - Thu Jul 03, 5:26PM CDT
It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs. Three of those staged breakouts, and nearly two-in-five on the list continued intently working on base patterns. Drugmakers...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 152

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 84

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 227

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 111

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 182

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 26

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 135

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Rush to ExoraPad: The Rise of $EXP Tokens Explained

Updated Category News Views 219

Investors Flock to ExoraPad as the $EXP Token Presale Surges As the digital currency landscape evolves, many investors are seeking the next big opportunity. ExoraPad has emerged as a focal point in this space, particularly for those involved with XRP. The ongoing presale for the $EXP token has garnered immense attention, attracting numerous investors eager to secure their...

Continue Reading
Key Insights on DFDS A/S Share Transactions Involving Managers

Updated Category News Views 251

Recent Share Transactions by DFDS A/S Leadership On February 25, a significant transaction was recorded involving Claus V. Hemmingsen, the Chair of the Board of Directors for DFDS A/S, who purchased 5,000 shares of the company. This action showcases the confidence of the company’s leadership in its growth trajectory and operational strategy. Regulatory Obligations Under...

Continue Reading
First Guaranty Bancshares Reaches New Stock Milestone

Updated Category News Views 253

First Guaranty Bancshares Achieves New Milestone First Guaranty Bancshares Inc (NASDAQ: FGBI) has recently achieved a notable milestone, with its stock hitting a new 52-week high of $13.38. This impressive leap highlights a phase of robust growth for the company, reflected in the rising stock price that has been buoyed by favorable market sentiments. Over the past year,...

Continue Reading
Pho Hoa & Jazen Tea Expands Southeast with New Location

Updated Category News Views 314

Pho Hoa & Jazen Tea Expands into the Southeast Pho Hoa & Jazen Tea is excited to announce the grand opening of a new restaurant in Marietta, marking an important milestone in the brand's expansion strategy. With over 40 years dedicated to perfecting pho noodle soup, the company is eager to bring its incredible Vietnamese culinary experience to new customers. Exciting New...

Continue Reading
IDT Corporation's Commitment to Shareholders with New Dividend

Updated Category News Views 74

IDT Corporation Announces Quarterly Dividend for Shareholders IDT Corporation (NYSE: IDT), a key player in communications and payment services, has recently made waves by declaring a quarterly cash dividend of $0.05 per share. This news was shared through a regulatory filing, illustrating the company's ongoing commitment to providing value to its shareholders. Details on...

Continue Reading